Clinical impact of rapid antimicrobial susceptibility testing in patients with bacteremia due to gram-negative bacilli
Revista Española de Quimioterapia · 2026
DOI: 10.37201/req/123.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2026. Verfasst von Fernando Cobo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Instituto de Investigación Biosanitaria ibs.GRANADA, Hospital Universitario Virgen de las Nieves. Granada, Spain. fern…. Hauptthemen laut MEDLINE: Bacteremia, Gram-Negative Bacterial Infections, Gram-Negative Bacteria, Anti-Bacterial Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Bacteremia and sepsis cause high morbidity and mortality worldwide. Rapid identification of bacteria and timely antimicrobial susceptibility testing (AST) can be crucial for patient survival. In the present study, we have compared isolates from patients whose ASTs were processed using MicroScan Walkaway Plus with those patients whose ASTs were processed more quickly using Vitek® Reveal™. We analyzed mortality, turnaround time to targeted therapy, and length of stay between the two groups, as well as other parameters. Material and methods: In this prospective study, 120 patients with bacteremia caused by Gram-negative bacilli were included. In 60 patients, conventional AST (MicroScan WalkAway Plus) was performed, whereas in the other 60 patients, rapid AST (Vitek® Reveal™) was carried out.
Results
The mortality rates were 13.3% and 38.3% for patients whose ASTs were performed with Vitek® Reveal™ and MicroScan WalkAway Plus, respectively (p=0.002). The average length of stay was 18 days per patient in the Vitek® Reveal™ group and 24.5 days for the MicroScan group (p=0.128). The average turnaround time was 12 hours per patient for Vitek® Reveal™ and 40 hours for MicroScan (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Instituto de Investigación Biosanitaria ibs.GRANADA, Hospital Universitario Virgen de las Nieves. Granada, Spain. fernando.cobo.sspa@juntadeandalucia.es.
- Biostatistics, Unidad de Gestión y Apoyo a la Investigación, Hospital Universitario Virgen de las Nieves, Granada, Spain.
- University Alfonso X El Sabio Mare Nostrum, Málaga, Spain.
- Department of Microbiology and Instituto de Investigación Biosanitaria ibs.GRANADA, Hospital Universitario Virgen de las Nieves. Granada, Spain.
ORCID-Profile: Fernando Cobo, María Del Carmen Olvera-Porcel, Rafael Ceballos-Atienza, José María Navarro-Marí
Zitieren
APA
Cobo, F., Olvera-Porcel, M. D. C., Ceballos-Atienza, R., & Navarro-Marí, J. M. (2026). Clinical impact of rapid antimicrobial susceptibility testing in patients with bacteremia due to gram-negative bacilli. Revista Española de Quimioterapia. https://doi.org/10.37201/req/123.2025
Vancouver
Cobo F, Olvera-Porcel MDC, Ceballos-Atienza R, Navarro-Marí JM. Clinical impact of rapid antimicrobial susceptibility testing in patients with bacteremia due to gram-negative bacilli. Revista Española de Quimioterapia. 2026. doi:10.37201/req/123.2025
BibTeX
@article{Cobo2026,
author = {Cobo, Fernando and Olvera-Porcel, María Del Carmen and Ceballos-Atienza, Rafael and Navarro-Marí, José María},
title = {Clinical impact of rapid antimicrobial susceptibility testing in patients with bacteremia due to gram-negative bacilli},
journal = {Revista Española de Quimioterapia},
year = {2026},
doi = {10.37201/req/123.2025}
}
EUVIMED